2021

Market Access
The State of The U.S. Biosimilar Market: Predictions for 2021

The US biosimilar market: Predictions for 2021

It has been five years since the first biosimilar launched in the United States market—marking the first steps in expanding access to innovative biologic-based treatments that help patients

Digital
telehealth to digital trials, customer engagement to healthcare data

What we’re expecting in 2021, and beyond…

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year.